Delivery Order SPE2DB20D1109-SPE2DB24FP71S
Award Date
8/15/24
Potential Completion Date
8/16/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order for the pharmaceutical drug Cosentyx (300mg dose) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $89,078.03 firm fixed-price contract was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 24, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the delivery of Cosentyx (secukinumab) 300mg dose prefilled syringes to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $12,637.98 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024. The contract has a completion date of December 3, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx 300 mg dose-2 syringes. The $4,767.17 firm fixed-price contract has a completion date of May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx (secukinumab) 300 mg dose prefilled syringes. The $16,595.61 firm-fixed-price delivery order contract has a performance period through May 7, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the prescription drug Cosentyx (secukinumab) in 300mg doses. The $7,588.88 firm-fixed-price delivery order contract has a completion date of September 20, 2024. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, collectively valued at up to $1.75 billion, to provide...
This federal contract award, valued at $1,574.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cosentyx (Secukinumab), a specialty medication used to treat various inflammatory conditions. The contract has an ultimate completion date of December 31, 2024, and is a firm fixed-price delivery order. This award is not associated with a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx (secukinumab) 300 mg dose injections. The contract has a ceiling value of $56,684.16 and is a firm fixed-price delivery order with a completion date of February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
This federal contract award is for the delivery of Cosentyx, a prescription drug product, to the Defense Logistics Agency (DLA). The $3,043.90 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. The IDC, which runs through November 2026, enables efficient government procurement of a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award, valued at $8,145.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Cosentyx (secukinumab) in 300mg doses. It is a firm fixed-price contract with a performance period extending through May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Cosentyx (secukinumab) 300mg dose syringes to the Defense Logistics Agency (DLA). The $11,139.37 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through the company's Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...